Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzo Biochem Inc (NYSE:ENZ)

9.98
Delayed Data
As of Oct 19
 +0.16 / +1.63%
Today’s Change
5.79
Today|||52-Week Range
12.04
+43.80%
Year-to-Date
No recent news for Enzo Biochem Inc.

Today’s Trading

Previous close9.82
Today’s open9.79
Day’s range9.61 - 9.99
Volume173,199
Average volume (3 months)209,417
Market cap$457.1M
Dividend yield--
Data as of 10/19/2017

Growth & Valuation

Earnings growth (last year)-105.15%
Earnings growth (this year)+60.00%
Earnings growth (next 5 years)--
Revenue growth (last year)+4.90%
P/E ratioNM
Price/Sales4.66
Price/Book5.14

Competitors

 Today’s
change
Today’s
% change
RDNTRadNet Inc-0.20-1.79%
NVTAInvitae Corp-0.19-1.92%
NTRANatera Inc-0.08-0.61%
NEONeogenomics Inc-0.26-2.87%
Data as of 10/19/2017

Financials

Next reporting dateDecember 11, 2017
EPS forecast (this quarter)-$0.01
Annual revenue (last year)$107.8M
Annual profit (last year)-$2.5M
Net profit margin-2.32%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Executive Officer &
Secretary
Elazar Rabbani
President, CFO, Treasurer &
Director
Barry W. Weiner
Corporate headquarters
New York, New York

Forecasts